{
  "abstract": "Postnatal depression is a psychiatric condition categorised by a major depressive episode with onset up to 1 year after delivery, with a prevalence of symptoms of around 10% in the UK and other high-income countries. 1–3 There has been little research on the prevalence of differing severity levels of postnatal depression, but in one clinical sample (n=292), 8.6% of women met criteria for severe depression.4 Similar to other episodes of depression, postnatal depression is characterised by persistent low mood and loss of pleasure or interests, occurring with associated symptoms such as changes in appetite and energy levels, disturbed sleep and low self-confidence.2 Postnatal depression is associated with impaired maternal–infant attachment; it can have multiple short- and long-term adverse effects for the mother and child and rarely can be associated with maternal suicide and infanticide.2 5",
  "authors": [
    {
      "affiliations": [],
      "name": "BMJ Publishing Group Ltd"
    }
  ],
  "title": "▼Zuranolone for the treatment of moderate or severe postnatal depression",
  "uid": "10073ec3-e40c-5ccd-9ca1-3e716dc23c23"
}